WOLVERINE TRADING, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 217 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$212,273
-71.2%
7,900
-61.5%
0.00%
Q2 2023$736,565
+210950.1%
20,500
+43.4%
0.00%
-100.0%
Q1 2023$349
-78.2%
14,300
-63.7%
0.00%
-66.7%
Q4 2022$1,598
-99.8%
39,400
+79.9%
0.00%
+200.0%
Q3 2022$729,000
+7.0%
21,900
+11.2%
0.00%0.0%
Q2 2022$681,000
-51.6%
19,700
-36.2%
0.00%0.0%
Q1 2022$1,407,000
-74.0%
30,869
-61.6%
0.00%
-83.3%
Q4 2021$5,415,000
-6.3%
80,400
-59.7%
0.01%
-64.7%
Q1 2020$5,778,000
-70.8%
199,446
-35.3%
0.02%
-64.6%
Q4 2019$19,789,000
+162.6%
308,227
+10.3%
0.05%
+118.2%
Q3 2019$7,536,000
-10.0%
279,518
-11.5%
0.02%
-8.3%
Q2 2019$8,371,000
+277.4%
315,872
+161.4%
0.02%
+242.9%
Q1 2019$2,218,000
+20.0%
120,844
-22.0%
0.01%
+40.0%
Q4 2018$1,849,000
-59.6%
154,857
-35.2%
0.01%
-50.0%
Q3 2018$4,578,000
+664.3%
238,800
+187.4%
0.01%
+400.0%
Q2 2018$599,0000.0%83,1000.0%0.00%0.0%
Q1 2018$599,000
+246.2%
83,100
+76.8%
0.00%
Q4 2017$173,000
-72.2%
47,000
-67.3%
0.00%
-100.0%
Q3 2017$622,000
+460.4%
143,611
+103.6%
0.00%
Q2 2017$111,000
-32.7%
70,553
-19.4%
0.00%
Q1 2017$165,000
-1.8%
87,569
-19.4%
0.00%
Q4 2016$168,000
-81.5%
108,700
-12.7%
0.00%
-100.0%
Q3 2016$909,000
+36.1%
124,500
+1.0%
0.00%0.0%
Q2 2016$668,000123,3000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders